Fund moves

Alkermes (ALKS): Avoro Capital Advisors LLC reduced its stake -840K shares

Avoro Capital Advisors LLC reduced its stake in Alkermes, per its Q4 2025 13F.

1.4M
Shares reported · -840K vs prior quarter
0.39%
Disclosed portfolio weight
$39.2M
Reported value
Holdings as of
Dec 31, 2025
Filed
Mar 16, 2026

What stands out in this filing

  • 2,240,000 shares in Q3 2025, 1,400,000 now (−37.5% in share count).
  • Reported at $39.2M, 0.39% of the portfolio value in this 13F filing.
  • 9 other tracked managers reported the same kind of change for Q4 2025.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 2, 2026Insider · 2 peopleInsiders: 4 sales (~$2.4M)
  2. Feb 12, 2026Company filing · Form 8-K · Material agreement, Agreement endedCompleted buying or selling a business or assets, and signed an important agreement (and 3 more items)“On February 12, 2026, the Company and Avadel Pharmaceuticals plc (“Avadel”), completed the transactions contemplated by the previously announced Transaction Agreement (the “Original Transaction Agreement”) dated October 22, 2025, as amended by Amendment No.1 to the Transaction Agreement (the “Amendment”) dated November 18, 2025, by and between the Company and Avadel (as amended, the “Transaction Agreement”).”
  3. Feb 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 24, 2026, Richard F. Pops, Chairman and Chief Executive Officer of Alkermes plc (the “Company”), notified the Company’s board of directors (the “Board”) of his decision to retire from his position of Chief Executive Officer, effective July 31, 2026, following a distinguished 35 years of service in this role.”
  4. Feb 25, 2026Company filing · Form 8-K · ResultsReported its results
  5. Mar 2, 2026Insider · 4 peopleInsiders: 4 sales (~$709K)
  6. Mar 3, 2026InsiderOfficer sold ~$61K of ALKS shares in the open market

What came next

  1. Apr 1, 2026InsiderOfficer sold ~$320K of ALKS shares in the open market
  2. Apr 6, 2026InsiderOfficer sold ~$70K of ALKS shares in the open market
  3. May 1, 2026InsiderOfficer sold ~$301K of ALKS shares in the open market
  4. May 4, 2026InsiderOfficer sold ~$68K of ALKS shares in the open market
  5. May 5, 2026Company filing · Form 8-K · ResultsReported its results
  6. May 20, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 20, 2026, at the 2026 annual general meeting of shareholders (the “Annual Meeting”) of Alkermes plc (the “Company”), the Company’s shareholders approved amendments to the Alkermes plc 2018 Stock Option and Incentive Plan to, among other things, increase the number of the Company’s ordinary shares authorized for issuance thereunder by 5,900,000 (the plan as so amended, the “2018 Plan”).”
  7. May 29, 2026InsiderOfficer sold ~$687K of ALKS shares in the open market
  8. Jun 1, 2026InsiderOfficer sold ~$375K of ALKS shares in the open market
  9. Jun 4, 2026InsiderOfficer sold ~$88K of ALKS shares in the open market
  10. Jun 12, 2026InsiderDirector sold ~$90K of ALKS shares in the open market
  11. Jul 1, 2026Insider · 1 personInsiders: 2 sales (~$464K)
  12. Jul 6, 2026Company filing · Form 8-K · Agreement endedEnded an important agreement
  13. Jul 6, 2026InsiderOfficer sold ~$110K of ALKS shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Alkermes

For Alkermes, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 2 Congress trade reports dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALKS page.

How this filing works

Explore the data

Common questions

What does this filing report about Alkermes (ALKS) stock?

Avoro Capital Advisors LLC reduced its stake in Alkermes, per its Q4 2025 13F. Now 1.4M shares, $39.2M reported value, 0.39% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2025. Filed: Mar 16, 2026.

What stands out in this filing?

2,240,000 shares in Q3 2025, 1,400,000 now (−37.5% in share count). Reported at $39.2M, 0.39% of the portfolio value in this 13F filing. 9 other tracked managers reported the same kind of change for Q4 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Alkermes recently?

For Alkermes, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 2 Congress trade reports dated in the last 90 days. They are listed on the ALKS page.

Does this mean ALKS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Alkermes

Everything OQRO holds on this company is on its ALKS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data